LeonaBio (LONA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $5.29, -1.86% vs the prior close of $5.39.
- Volume 35.20K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LONA dips 1.9% to $5.29. Closed at $5.29, -1.86% vs the prior close of $5.39. Day range $4.91–$5.44, opened at $5.41.
LONA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LONA dips 1.9% to $5.29
- Closed at $5.29, -1.86% vs the prior close of $5.39. Day range $4.91–$5.44, opened at $5.41.
- Volume was 35.20K shares, 0.1x its 50-day average of 236.53K — lighter than usual.
- Price is -20.5% vs its 50-day average ($6.66) and -30.5% vs its 200-day average ($7.61).
- 52-week range $2.21–$14.21; today's close sits at 26% of that range, 62.8% below the 52-week high.
Oct 14, 2026 — LONA slides 16.2% to $5.39
- Closed at $5.39, -16.17% vs the prior close of $6.43. Day range $5.25–$6.33, opened at $6.33.
- Volume was 103.00K shares, 0.4x its 50-day average of 234.60K — lighter than usual.
- Price is -19.6% vs its 50-day average ($6.71) and -29.3% vs its 200-day average ($7.62).
- 52-week range $2.21–$14.21; today's close sits at 26% of that range, 62.1% below the 52-week high.
Oct 13, 2026 — LONA jumps 4.3% to $6.43
- Closed at $6.43, +4.30% vs the prior close of $6.16. Day range $5.65–$6.72, opened at $6.06.
- Volume was 57.40K shares, 0.2x its 50-day average of 233.67K — lighter than usual.
- Price is -4.8% vs its 50-day average ($6.75) and -15.8% vs its 200-day average ($7.63).
- 52-week range $2.21–$14.21; today's close sits at 35% of that range, 54.8% below the 52-week high.
Oct 12, 2026 — LONA jumps 7.2% to $6.16
- Closed at $6.16, +7.22% vs the prior close of $5.75. Day range $5.57–$6.40, opened at $5.82.
- Volume was 386.30K shares, 1.7x its 50-day average of 226.08K.
- Price is -9.0% vs its 50-day average ($6.77) and -19.3% vs its 200-day average ($7.64).
- 52-week range $2.21–$14.21; today's close sits at 33% of that range, 56.6% below the 52-week high.
Oct 9, 2026 — LONA ends flat (+0.0%) to $5.75
- Closed at $5.75, +0.00% vs the prior close of $5.75. Day range $5.56–$6.10, opened at $5.82.
- Volume was 66.70K shares, 0.3x its 50-day average of 225.11K — lighter than usual.
- Price is -15.3% vs its 50-day average ($6.79) and -24.8% vs its 200-day average ($7.64).
- 52-week range $2.21–$14.21; today's close sits at 29% of that range, 59.5% below the 52-week high.
Oct 8, 2026 — LONA dips 1.4% to $5.75
- Closed at $5.75, -1.37% vs the prior close of $5.83. Day range $5.51–$6.07, opened at $5.78.
- Volume was 134.60K shares, 0.6x its 50-day average of 222.71K.
- Price is -15.7% vs its 50-day average ($6.82) and -24.9% vs its 200-day average ($7.65).
- 52-week range $2.21–$14.21; today's close sits at 29% of that range, 59.5% below the 52-week high.
Oct 7, 2026 — LONA rises 1.4% to $5.83, 7 up days in a row
- Closed at $5.83, +1.39% vs the prior close of $5.75. Day range $5.61–$6.21, opened at $5.77.
- Volume was 178.10K shares, 0.8x its 50-day average of 219.54K.
- Price is -14.8% vs its 50-day average ($6.85) and -23.9% vs its 200-day average ($7.66).
- 52-week range $2.21–$14.21; today's close sits at 30% of that range, 59.0% below the 52-week high.
- That makes 7 straight gains.
Oct 6, 2026 — LONA jumps 3.0% to $5.75, 6 up days in a row
- Closed at $5.75, +3.05% vs the prior close of $5.58. Day range $5.25–$5.88, opened at $5.63.
- Volume was 175.60K shares, 0.8x its 50-day average of 216.31K.
- Price is -16.3% vs its 50-day average ($6.87) and -25.0% vs its 200-day average ($7.66).
- 52-week range $2.21–$14.21; today's close sits at 29% of that range, 59.5% below the 52-week high.
- That makes 6 straight gains.
Oct 5, 2026 — LONA jumps 15.8% to $5.58, 5 up days in a row
- Closed at $5.58, +15.77% vs the prior close of $4.82. Day range $4.51–$5.72, opened at $4.75.
- Volume was 295.60K shares, 1.4x its 50-day average of 210.59K.
- Price is -19.1% vs its 50-day average ($6.90) and -27.1% vs its 200-day average ($7.66).
- 52-week range $2.21–$14.21; today's close sits at 28% of that range, 60.7% below the 52-week high.
- That makes 5 straight gains.
Oct 2, 2026 — LONA jumps 10.0% to $4.82, 4 up days in a row
- Closed at $4.82, +10.05% vs the prior close of $4.38. Day range $4.18–$4.90, opened at $4.44.
- Volume was 332.10K shares, 1.6x its 50-day average of 204.07K.
- Price is -30.5% vs its 50-day average ($6.94) and -37.0% vs its 200-day average ($7.65).
- 52-week range $2.21–$14.21; today's close sits at 22% of that range, 66.1% below the 52-week high.
- That makes 4 straight gains.
LONA latest news & SEC filings
Every SEC filing by or about LONA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 3, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 31, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 25, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 20, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$19.01M (prior year -$6.97M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.80 (prior year -$1.78) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade LONA
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 9.29% (largest 34.9%). That is a volatile stock.
- Liquidity: about 507.11K shares (≈$2.68M) trade per day on average.
- 52-week position: $5.29 vs a range of $2.21–$14.21 (26% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Sep 18, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 10 sales; latest: Mark James Litton sold 5,156 shares on Mar 4, 2026.
- Latest filings: 8-K Sep 22, 2026; 8-K Aug 26, 2026; 10-Q Aug 14, 2026.
- Share count: 9.42M shares outstanding (Aug 4, 2026), -76.1% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
LONA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 5.41 | 5.44 | 4.91 | 5.29 | 35.20K |
| Oct 14, 2026 | 6.33 | 6.33 | 5.25 | 5.39 | 103.00K |
| Oct 13, 2026 | 6.06 | 6.72 | 5.65 | 6.43 | 57.40K |
| Oct 12, 2026 | 5.82 | 6.40 | 5.57 | 6.16 | 386.30K |
| Oct 9, 2026 | 5.82 | 6.10 | 5.56 | 5.75 | 66.70K |
| Oct 8, 2026 | 5.78 | 6.07 | 5.51 | 5.75 | 134.60K |
| Oct 7, 2026 | 5.77 | 6.21 | 5.61 | 5.83 | 178.10K |
| Oct 6, 2026 | 5.63 | 5.88 | 5.25 | 5.75 | 175.60K |
| Oct 5, 2026 | 4.75 | 5.72 | 4.51 | 5.58 | 295.60K |
| Oct 2, 2026 | 4.44 | 4.90 | 4.18 | 4.82 | 332.10K |
| Oct 1, 2026 | 3.52 | 5.34 | 3.42 | 4.38 | 6.30M |
| Sep 30, 2026 | 3.51 | 3.59 | 3.31 | 3.57 | 40.30K |
| Sep 29, 2026 | 2.80 | 3.75 | 2.57 | 3.51 | 439.10K |
| Sep 28, 2026 | 3.30 | 3.30 | 2.21 | 2.87 | 948.90K |
| Sep 25, 2026 | 5.19 | 5.59 | 3.12 | 3.25 | 343.70K |
| Sep 24, 2026 | 6.04 | 6.32 | 4.90 | 4.99 | 151.00K |
| Sep 23, 2026 | 6.35 | 6.35 | 5.69 | 5.89 | 21.40K |
| Sep 22, 2026 | 6.40 | 6.75 | 5.95 | 6.05 | 34.90K |
| Sep 21, 2026 | 6.72 | 6.76 | 6.23 | 6.33 | 45.60K |
| Sep 18, 2026 | 7.59 | 7.66 | 6.61 | 6.79 | 52.30K |
About LeonaBio
LeonaBio (LONA) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in BOTHELL, WA. Fiscal year ends December 31. SEC CIK 1620463.
LONA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Fred Callori | Director | Jun 24, 2026 |
| Joseph Edelman | Director | Jul 10, 2026 |
| John M Jr Fluke | Director | Apr 13, 2026 |
| Natalie C. Holles | Director | Jun 24, 2026 |
| James A Johnson | Director | Jun 24, 2026 |
| Barbara Kosacz | Director | Jun 24, 2026 |
| Mark James Litton | PRESIDENT and CEO | Apr 13, 2026 |
| Advisors Llc Perceptive | Director | Jul 10, 2026 |
| Life Sciences Master Fund Ltd Perceptive | Director | Jul 10, 2026 |
| Grant Pickering | Director | Jun 24, 2026 |
| Michael A. Panzara | Director | Jun 24, 2026 |
| Xontogeny Venture Fund Ii, Lp Perceptive | Director | Dec 23, 2025 |
| Kelly A Romano | Director | Jun 24, 2026 |
| Peter B. Silverman | Director | Jun 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kevin Church | CHIEF SCIENTIFIC OFFICER | Apr 13, 2026 |
| Mark James Litton | PRESIDENT and CEO | Apr 13, 2026 |
| Robert Renninger | CHIEF FINANCIAL OFFICER | Apr 13, 2026 |
| Martin Javier San | CHIEF MEDICAL OFFICER | Apr 13, 2026 |
| Mark Worthington | GENERAL COUNSEL and CCO | Apr 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 4, 2026 | Mark James Litton | Sale | 5,156 | $5.37 |
| Mar 4, 2026 | Martin Javier San | Sale | 1,720 | $5.37 |
| Mar 4, 2026 | Mark Worthington | Sale | 1,328 | $5.37 |
| Mar 4, 2026 | Kevin Church | Sale | 1,359 | $5.37 |
| Mar 4, 2026 | Robert Renninger | Sale | 906 | $5.37 |
| Jan 2, 2026 | Robert Renninger | Sale | 297 | $6.88 |
| Jan 2, 2026 | Mark James Litton | Sale | 2,586 | $6.88 |
| Jan 2, 2026 | Kevin Church | Sale | 876 | $6.88 |
| Jan 2, 2026 | Mark Worthington | Sale | 876 | $6.88 |
| Jan 2, 2026 | Martin Javier San | Sale | 1,644 | $6.88 |
LONA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-105.61M | -24.70 | $-45.73M |
| Dec 31, 2024 | — | $-96.94M | -25.19 | $-97.17M |
| Dec 31, 2023 | — | $-117.67M | -3.09 | $-100.75M |
| Dec 31, 2022 | — | $-95.64M | -2.53 | $-72.47M |
| Dec 31, 2021 | — | $-54.85M | -1.49 | $-43.10M |
Latest balance sheet: total assets $56.89M, total liabilities $23.30M, cash $32.32M (as of Jun 30, 2026).
LONA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $7.97 |
| May 7, 2026 | 8-K Item 2.02 (results) | $9.86 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $9.68 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $4.01 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $3.70 |
| May 9, 2025 | 8-K Item 2.02 (results) | $2.54 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $4.23 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $7.50 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
| Jan 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LONA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.